CD44 and ovarian carcinoma: We previously showed, using gene expression microarray, that Ck18 expression is 7-fold higher (P = 0.0007) in CD44+/MyD88+ EOC stem cells compared to the CD44−/MyD88− mature ovarian cancer stem cells (mOCCs) [14].